BrdU Antibodies

Santa Cruz Biotechnology features a diverse variety of BrdU monoclonal antibodies for the detection and analysis of bromodeoxyuridine (BrdU) incorporation in biological samples. BrdU monoclonal antibodies excel in multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Bromodeoxyuridine is a thymidine analog that incorporates into newly synthesized DNA, making BrdU detection essential for studying cell proliferation and DNA synthesis. Understanding the dynamics of cell division and growth plays a vital role in cancer research, developmental biology, and regenerative medicine. Accurate measurement of BrdU incorporation reveals important insights into cellular processes and the effects of therapeutic interventions. BrdU monoclonal antibodies enable precise tracking of DNA synthesis in dividing cells, supporting research in cell cycle regulation and tissue development. Monitoring BrdU incorporation helps evaluate cellular responses to various experimental conditions and treatments. Santa Cruz Biotechnology monoclonal antibodies for BrdU detection continue to support breakthrough discoveries in cell biology and biomedical research.